Jones Cecilia
SEC CIK 1840056 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | CFO | 58.1K | — | $895.7K | 22 | 2023-06-28 | 2026-04-02 |
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-06 16:08 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +8,500 | 58.1K | +17% | $0 |
| DT | 2026-04-06 16:08 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $34.71 | -3,141 | 55.0K | -5% | -$109.0K |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +17.0K | 50.9K | +50% | $0 |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $28.96 | -5,035 | 49.3K | -9% | -$145.8K |
| D | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $27.09 | -2,932 | 37.4K | -7% | -$79.4K |
| D | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +6,000 | 40.3K | +17% | $0 |
| D | 2025-09-30 | 2025-09-26 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $36.77 | -3,651 | 33.9K | -10% | -$134.2K |
| D | 2025-09-30 | 2025-09-26 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +7,472 | 37.5K | +25% | $0 |
| D | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +6,000 | 31.8K | +23% | $0 |
| D | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $33.54 | -1,780 | 30.0K | -6% | -$59.7K |
| DM | 2025-03-04 | 2025-03-01 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +7,667 | 27.5K | +39% | $0 |
| DM | 2025-03-04 | 2025-03-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $35.54 | -2,275 | 21.8K | -9% | -$80.9K |
| D | 2024-09-30 | 2024-09-26 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $49.03 | -2,542 | 20.2K | -11% | -$124.6K |
| D | 2024-09-30 | 2024-09-26 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +7,473 | 22.7K | +49% | $0 |
| D | 2024-03-05 | 2024-03-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $32.57 | -672 | 14.8K | -4% | -$21.9K |
| D | 2024-03-05 | 2024-03-01 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +2,000 | 15.5K | +15% | $0 |
| D | 2024-01-24 | 2024-01-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $21.64 | -1,886 | 13.1K | -13% | -$40.8K |
| D | 2024-01-24 | 2024-01-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +5,380 | 15.0K | +56% | $0 |
| D | 2023-09-28 | 2023-09-26 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +7,472 | 11.8K | +174% | $0 |
| D | 2023-09-28 | 2023-09-28 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $24.79 | -2,179 | 9,575 | -19% | -$54.0K |
| D | 2023-06-30 | 2023-06-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | S - Sale+OE | $28.36 | -1,597 | 3,783 | -30% | -$45.3K |
| D | 2023-06-30 | 2023-06-28 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | CFO | M - OptEx | $0.00 | +5,380 | 5,380 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations